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The assessment of human exposure to environ-
mental chemicals requires an understanding of
the source of the chemical, its transport and
environmental fate, and subsequent routes of
entry into the body. Once an exposure occurs,
it is necessary to have data on its absorption,
distribution, metabolism, and elimination. This
is a complex undertaking for any environmental
chemical and for any potentially exposed popu-
lation. It is especially challenging in the evalua-
tion of exposures to children at various stages of
their development. The activity of the endocrine
system is vital throughout all stages of human
life, but it is particularly critical during the stages
of greatest human development—in utero, dur-
ing infancy, early childhood, and puberty.
Exogenous chemicals such as endocrine
disruptors are of special interest because they
mimic, block, or in some way alter the activity
of endogenous chemicals that are synthesized
by the endocrine system (National Research
Council 1999). The endocrine system as used
here refers to all compounds involved in com-
municating information that are secreted by
cells. These compounds can have autocrine
effects (on the same cell), paracrine effects (on
cells nearby), and classic endocrine effects
(secretion is into the blood stream, potentially
exposing all cells to the compound) (National
Research Council 1999). The class of endocrine
disruptors about which we know the most are
those that mimic or block endogenous estro-
gens. Examples of synthetic chemicals with
reported estrogenic activity are listed in Table 1.
Dietary exposures to some potential endo-
crine disruptors have been quantified for
adults. For example, phytoestrogen consump-
tion (expressed as total bioﬂavoids) is estimated
at 1 g/day, whereas 100 g of wheat germ with
2 ppm zearalenone provides 200 µg/day
(National Research Council 1999). The esti-
mated exposure to dichlorodiphenyltrichloro-
ethane (DDT) from all dietary sources in
the general U.S. population is 0.01 µg/day,
and estimated exposure to polychlorinated
biphenyls (PCBs) is 0.002 µg/day (National
Research Council 1999). However, exposures
to environmental contaminants may vary
among countries; for example, in areas where
DDT is still used extensively, breast milk may
be a signiﬁcant source of DDT exposure for an
infant (Kashyap et al. 1991).
Akland et al. (2000) have modeled the var-
ious factors influencing dietary exposures of
young children. However, at different human
developmental stages, not only do the diets
vary but also the primary route of human
exposure may vary; for example, Hubal et al.
(2000) described the challenge of assessing
children’s residential exposure to pesticides.
In addition to dietary sources, other aspects
of exposure assessment that should be consid-
ered in developing a research initiative include
timing or age at exposure; the rate of exposure
(frequency and duration); qualitative versus
quantitative assessment; sample collection and
storage; sample analysis; and exposures assessed
to test hypotheses and those to generate addi-
tional hypotheses. Each of these aspects is
treated in more detail below.
Routes of Exposure and
Mechanisms of Response
The earliest relevant exposures may occur
before conception. For example, the number of
female births relative to total births to parents
who resided in the most highly dioxin-contam-
inated area around Seveso, Italy, at the time of
the dioxin release in 1976 was statistically
higher than expected for the 8 years after the
accident, presumably because of high dioxin
exposures to the father (Mocarelli et al. 2000).
Epigenetic imprinting of genes is the basis
for the ﬁnding that chromosomes provided to
an embryo by the egg and sperm are funda-
mentally different (Jiang et al. 1998).
Epigenetic imprinting refers to the mecha-
nism(s) by which hormones and chemicals
that mimic hormones permanently alter cellu-
lar functions when exposure occurs during
organogenesis in fetal life; this also occurs
inappropriately during carcinogenesis, causing
a breakdown in cell cycle control systems. One
mechanism that is generating considerable
interest is the epigenetic modiﬁcation of DNA
by addition of methyl groups to speciﬁc bases
located in the promoter region of genes. DNA
methylation consists of the covalent addition
of methyl groups to the 5-position of cytosines
that are 5´ to guanine nucleotides in the DNA
sequence. CpG dinucleotide sequences can
occur as clusters in regions known as CpG
islands, which are normally protected from
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storage protocols; and the selection and documentation of analytic methods. The methods for expo-
sure data collection and analysis must be sufﬁciently robust to accommodate the a priori hypotheses
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Frommer 1987). When methylation occurs at
these normally protected sites, changes occur
in chromosome structure and in the capacity
for the gene controlled by the promoter to be
activated. Inappropriate methylation of genes
can act in a manner analogous to that of a
classic genetic mutation and can cause the lack
of a functional protein product. The result can
be a subsequent breakdown in homeostasis,
producing functional changes that could easily
be missed in short-term tests for acute toxicity
in adults or in vitro tests for classic gene muta-
tions involving changes in base sequences (Jost
and Saluz 1993). Thus, current toxicologic
testing methods might not reveal this type of
functional damage.
Epigenetic imprinting of genes is impor-
tant for endocrine disruption research. For
example, genes contributed to the embryo via
the sperm are required for placental forma-
tion: When an egg has a pronucleus from
another female injected into it, no placenta
develops; in contrast, an egg that has its
pronucleus replaced such that all genes are
paternal does not develop into a normal
embryo, but the placenta develops. There are
intriguing observations that may relate to
imprinting effects of chemicals. For example,
when pregnant female mice (F0 generation)
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Table 1. Examples of endocrine-disrupting chemicals with reported estrogenic activity and examples of potential sources.
Compound Source Reference
Organochlorine compounds
Chlordecone (Kepone) Pest control Gellert 1978; Hammond et al. 1979; Soto et al. 1994, 1995; Flouriot et al. 1995
Dieldrin Soto et al. 1994, 1995; Sonnenschein et al. 1995; Arnold et al. 1996
Endosulfan Soto et al. 1994, 1995; Sonnenschein et al. 1995; Arnold et al. 1996
α-Endosulfan Soto et al. 1994, 1995
β-Endosulfan Soto et al. 1994, 1995
DDT (technical grades and isomers) Welch et al. 1969; Bitman and Cecil 1970; Soto et al. 1994, 1995, 1997
Lindane Soto et al. 1995
Methoxychlor Tullner 1961; Bitman and Cecil 1970; Bulger et al. 1978; Cummings and 
Metcalf 1994, 1995; vom Saal et al. 1995; Soto et al. 1995
Toxaphene Soto et al. 1994, 1995; Sonnenschein et al. 1995; Arnold et al. 1996
PCBs Dielectric ﬂuids; contaminated soils; ﬁsh Bitman and Cecil 1970; Ecobichon and MacKenzie 1974; Gellert 1978;
Jansen et al. 1993
Phenolics
Alkylphenol ethoxylates (APEs) Cleaning agents and surfactants White et al. 1994; Sumpter and Jobling 1995; Jobling et al. 1996;
Routledge and Sumpter 1996
4-Alkylphenols Used in manufacture of APEs Soto et al. 1991, 1995; Jobling and Sumpter 1993; White et al. 1994;
Bicknell et al. 1995; Fluoriot et al. 1995; Jobling et al. 1995, 1996;
Sonnenschein et al. 1995; Sumpter and Jobling 1995; Ren et al. 1996;
Routledge and Sumpter 1996
Bisphenol A Epoxy resins; polycarbonate plastic products Brotons et al. 1995; Krishnan et al. 1995; Sonnenschein et al. 1995;
Soto et al. 1995, 1997; Sumpter and Jobling 1995; Olea et al. 1996;
Nagel et al. 1998
Biphenylols (three isomers) Soto et al. 1995, 1997
Chlorinated biphenyldiol (1 isomer) Korach et al. 1988
Chlorinated biphenylols (> 10 isomers) Korach et al. 1988; Jansen et al. 1993; Bergeron et al. 1994; Crews et al. 1995;
Soto et al. 1995; Arnold et al. 1996
Other synthetic compounds
Butylated hydroxyanisole (BHA) Food/drug preservative Jobling et al. 1995; Soto et al. 1995
Diphenylphthalate Jobling et al. 1995
Butylbenzylphthalate (BBP) Plasticizer for polyvinyl and cellulosic resin Sonnenschein et al. 1995; Soto et al. 1995, 1997
Di-n-butylphalate (DBP) Soto et al. 1998
Isoﬂavones
Diadzein Alfalfa, soybeans Shutt and Cox 1972; Verdeal et al. 1980; Sathyamoorthy et al. 1994
Formonetin Clover, alfalfa Miksicek 1995
Genistein Alfalfa, soybeans Shutt and Cox 1972; Verdeal et al. 1980; Miksicek 1995
Biochanin A Clover, alfalfa Miksicek 1995
Flavones, ﬂavonols, ﬂavanones
Apigenin Chamomile, parsley, plantain Miksicek 1995
Luteolina Plantain, chamomile Markaverich et al. 1988; Miksicek 1995
Kaempferol Cabbage, nettles, asparagus, raspberry, Markaverich et al. 1995
may apple
Naringenina Thyme Miksicek 1995; Ruh et al. 1995
Chalcones Licorice
2,4,4´-Trihydroxyisoliquiritigenin Miksicek 1995
2´,4,4´,6´-Tetrahydroxynaringenin chalcone Miksicek 1995
2´4,4´6´-Tetrahydroxydihydrophloretin Miksicek 1995
Indolo[3,2-β]carbazole Brassicas Liu et al. 1994
Coumestrol Alfalfa, clover, soy, lima beans, pinto beans Martin et al. 1978; Verdeal et al. 1980; Soto et al. 1992; Nagel et al. 1998
Equol Shutt and Cox 1972; Tang and Adams 1980; Sathyamoorthy et al. 1994;
vom Saal et al. 1995; Nagel et al. 1998
Nordihydroguaiaretic acid (NDGA) Chaparral, desert cactus, edible oil stabilizer Sathyamoorthy et al.1994
Zearalenone Produced by Fusarium fungi on moldy corn, Martin et al. 1978; Verdeal et al. 1980;
wheat, barley Soto et al. 1992
Zearalanol Derivative of zearalenone Martin et al. 1978; Verdeal et al. 1980; Soto et al. 1992
β-Sitosterol Saw palmetto, aloe vera, soybeans Rosenblum et al. 1993; MacLatchy and Van Der Kraak 1995
Note: This table has been modiﬁed from the original source (National Research Council 1999), and the list of potential sources is not comprehensive.
aAlso has antiestrogenic activity, as does quercetin (found in chamomile, raspberry, cabbage, nettles, asparagus).are treated with the estrogenic drug diethyl-
stilbestrol (DES), the male and female off-
spring (F1 generation) have a spectrum of
abnormalities, including cancers that appear
in mid-life. Interestingly, the F2 offspring
produced by the exposed F1 generation
(mated to control mice) showed a signiﬁcant
increase in cancers, similar to F1 animals that
were exposed directly via their mothers
(Newbold et al. 1998; Turusov et al. 1992).
There is extensive evidence that alterations in
maternal physiology can alter the develop-
ment of her fetus. However, how genes in
sperm might transmit a “memory” of prior
environmental chemical exposure to an
embryo remains to be determined. Although
there is intensive investigation of imprinting
mechanisms, the mechanisms by which
chemicals alter gene activity without causing
classic mutations remain unresolved.
In general, the period of highest suscepti-
bility to adverse effects from environmental
exposures is thought to be the in utero period.
In utero exposures result from mobilization in
the mother’s body of chemical agents that can
cross the placenta and enter into the fetal blood
flow; the mother may have been exposed to
these chemical agents before pregnancy or dur-
ing pregnancy. Postnatally, the infant may be
at risk from exposures occurring from foods,
such as breast milk, or from mouthing non-
food objects, such as chips of lead-based paint,
toys, and stuffed animals, that may have
endocrine-disrupting contaminants (EDCs) on
their surface, which are solubilized in the
mouth and then swallowed. Infant exposures
through breast-feeding may result from expo-
sures of the mother before or during pregnancy
but also during the breast-feeding period
(National Research Council 1999). Research
on chemicals found in breast milk centers on
the persistent organic pollutants, such as PCBs,
polychlorinated dibenzo-p-dioxins, polychlori-
nated dibenzofurans, and organochlorine pesti-
cides (LaKind et al. 2001). Metals, including
lead, mercury, and cadmium, have also been
reported in breast milk, but they do not usually
accumulate to higher concentrations in breast
milk than in blood. Chemical exposures to the
mother may result from work, the ambient or
home environment, diet, or carrying home of
contaminants by another person living at the
residence (Fenske 1997; Fingerhut et al. 1991;
National Research Council 1999; Rogan et al.
1988; Vine et al. 2000; Weisglas-Kuperus et
al. 2000).
Human routes of exposure to environ-
mental toxicants include oral, dermal, and
inhalation. In children, oral exposure may
occur by the direct ingestion of contaminated
environmental media (e.g., food, water, sur-
face and carpet dust, and soil) and as a result
of the transfer of toxic materials to the mouth
from toys and other objects or from the
child’s hands. Dermal exposure occurs when
the skin is in direct contact with the contami-
nated media, such as water, soil, or surfaces.
Inhalation of airborne particulate or gases and
vapors may introduce toxic substances into
the respiratory tract, where material may exert
an effect directly at the site—that is, at the
portal of entry into the body—or the material
may be transported to another organ where
the toxic effects occur.
The route of entry into the body affects the
internal dose to the child. Hand-to-mouth
activity provides direct oral ingestion of mater-
ial over an extended period of time, whereas
oral exposures to food are more discontinuous.
Covering the skin with a dressing that holds in
water vapor decreases the ability of the skin to
act as a barrier to entry of a material into the
body, because the humidity macerates the skin
and makes it more permeable. Moreover, some
body sites have skin that presents a better bar-
rier than do other sites. For example, Maibach
et al. (1971) demonstrated that parathion
uptake from dermal exposure resulted in a 2-
fold increase if the material was applied to the
ball of the foot, abdomen, or dorsa of the
hands compared with application to the fore-
arm (the authors did not specify the location of
testing on the forearm). Similarly, the increase
was 4-fold when applied to the scalp, jaw
angle, or forehead, 5-fold at the ear canal, and
12-fold for the scrotum. Studies with
malathion showed the same general trends
(Maibach et al. 1971).
If the toxic agent is an airborne gas or
vapor with relatively constant concentration in
the home, the dose delivered to the lung is less
during one hour of sleep, when the breathing
rate and volume is lower, than during one hour
of vigorous play time. Particulate deposition in
the respiratory tract, which depends on particle
size and breathing rate, may also change
because of activity level (Phalen et al. 1988).
Solubility of the compound, motility of the
gastrointestinal tract, and age of the child are
important factors in understanding absorption
(dose) from any exposure (Rogan 1980).
Often exposure is considered to be con-
stant over time, with the total dose estimated
by the cumulative exposure, calculated as the
product of concentration or intensity and
time. However, if exposure is not constant
over time, the same total cumulative expo-
sure, delivered in different patterns, may pro-
duce different biologic effects. For example,
in animals exposed to the same cumulative
exposure to carbon tetrachloride, differences
were seen in the type and distribution of vac-
uolation and necrosis in stained sections of
liver and in liver enzyme activity (Colborn et
al. 1993; Fry 1995). In children, it is possible
that the pattern of exposure may produce dif-
ferent effects even when the total exposure
is equivalent.
Timing, Frequency, and
Duration of Exposure
The extensive literature concerning the effects
of disruption of normal endocrine function
during critical periods in development has
been reviewed (National Research Council
1999). The importance of a critical period is
that it represents a developmental window
during which endocrine signals can program
genes, which regulate the functioning of a
tissue. If proper programming fails to occur
during this time, structural or functional
abnormalities can result. The term “endocrine
signals” is used broadly here to refer to any
signaling molecule, not just those classically
considered as being carried via blood.
The developmental consequences of the
disruption of endocrine function due to genetic
defects in humans are well known. For exam-
ple, the absence of a functional enzyme (5α-
reductase) required to metabolize testosterone
to the more potent androgen 5α-dihydrotestos-
terone results in a failure of masculinization of
the external genitalia and prostate in male
fetuses. Turner syndrome occurs in individuals
with XY chromosomes due to mutation of the
androgen receptor gene; this results in the
development of female external genitalia.
Developmental abnormalities due to exposure
to endocrine-disrupting drugs (e.g., DES) are
also well documented (George and Wilson
1994; Mittendorf 1995; Swan and vom Saal
2001). The importance of small changes in the
concentration of endocrine-signaling molecules
during critical periods in development has been
studied extensively in laboratory animals and
wildlife (Colborn et al. 1993; Fry 1995;
Guillette et al. 1995; vom Saal 1989; vom Saal
et al. 1997).
One of the most surprising discoveries
over the last few decades is the remarkable
conservation of genetic and hormonal systems
involved in regulating development in multi-
cellular animals. We know from develop-
mental biology that the same genetic and
hormonal systems are used in various ways to
achieve the ﬁnal formation of the adult. This
argues strongly that the working hypothesis
should be that if developmental disruption by
a chemical occurs in one species then the
chemical can be expected to result in disrup-
tion in many (perhaps most) other species.
This does not mean that the consequences of
disruption by a chemical on adult form and
function will necessarily appear similar based
on superﬁcial examination.
For humans, there is more information cur-
rently available about the consequences of
endocrine disruption during critical periods in
fetal life than during neonatal life, infancy,
childhood, or adolescence (Majdic et al. 1997;
Sharpe and Skakkebaek 1993; Winter et al.
1976). This gap in understanding of the conse-
quences of endocrine disruption in postnatal
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comes to relate to exposures during these times.
The fetal period appears to be differen-
tially sensitive to exogenous hormone expo-
sure. The paradigmatic exposure is to DES, a
stilbene estrogen used to prevent spontaneous
abortion in the 1950s and 1960s. Fetal expo-
sure to DES resulted in genital tract abnor-
malities in a high percentage, and vaginal
clear cell adenocarcinoma in an estimated 1%
at a very young age (Herbst 2000). Although
it has not been without consequence for the
mothers, nothing so dramatic as the effects in
children exposed to DES has been described
(Titus-Ernstoff et al. 2001).
Many decades ago there was less concern
about exposure to toxic chemicals during preg-
nancy because it was a presumed that a “pla-
cental barrier” would block the transport of the
toxicant to the fetus. This assumption is now
known to be incorrect. Many of the chemicals
listed in Table 1 have been shown or are
presumed (based on their structure) to cross
the placenta and enter the fetal circulation.
Exposure during any developmental period is
complicated because the factors that inﬂuence
absorption, circulation in blood, uptake into
tissues, and rates of metabolism and clearance
undergo changes throughout development.
The complexity of development makes it
essential to study exposure at each stage rather
than to attempt to characterize risk associated
with developmental exposure based on data
from adults. In the executive summary of the
National Research Council report on diets
of infants and children (National Research
Council 1993), the panel stated: “A funda-
mental maxim of pediatric medicine is that
children are not little adults.” Data collected
from exposures in adulthood are not likely to
predict those of other life stages, such as devel-
opment or old age.
The difference between males and females
regarding endocrine disruption is an impor-
tant issue about which there is considerable
speculation, but typically, direct comparisons
of effects in males and females are not made.
In general, adult females are more difﬁcult to
study than males because the cyclic nature of
hormones in females complicates studies of
processes that are influenced by these hor-
mones (e.g., estradiol and progesterone).
However, there has been speculation that
males are more sensitive to the disruptive
effects of EDCs during development (Swan
and vom Saal 2001). There are theoretical rea-
sons for this hypothesis: Males are the actively
differentiating sex and females the default sex,
so there is a greater possibility of interference
with the process of masculinization than of
feminization. Also, the epidemiologic evidence
appears to support the prediction that mas-
culinization is being disrupted, based on
reports of a secular trend for changes in sperm
count, hypospadias, cryptochidism, and testic-
ular cancer, all of which have been linked to
disruption during fetal life of the male repro-
ductive organs (Skakkebaek et al. 2001). It is
easier to detect abnormalities of the genitals of
males than in those of females, and historic
data that would be informative about trends
in female reproductive dysfunction are not
available.
Information must be collected to charac-
terize exposures throughout the span of devel-
opment, from prenatal life to postnatal life,
through adolescence. Postnatal exposure must
be characterized separately in each period of
time representing substantial change in the
activity of the child: from crib to limited play
areas to full mobility at home and within the
larger community. Speciﬁc recommendations
have been made to assess dietary exposures
yearly from birth to 5 years old, once between
5 and 10 years, and once between 11 and 18
years (National Research Council 1993).
Qualitative and Quantitative
Data Needs
Qualitative exposure data are derived from
interviews, questionnaires, and self-reports and
may be expressed in relative terms (e.g., “expo-
sure was twice as high when I was a child”) or
indicate the presence or absence of a potential
exposure (e.g., “I did not live near a hazardous
waste site”). “Quantitative exposure data” gen-
erally refers to the numeric results from analy-
ses for a contaminant in a specific media; a
typical result might be reported as mass per
unit volume (e.g., milligrams per cubic meter).
To capture the information needed for
exposure assessment and subsequent risk assess-
ment, a combination of environmental and
biologic data are needed (Dietrich et al. 1993;
Hammond and Dietrich 1990; Que Hee et al.
1985). Factors that modulate exposure may be
identiﬁed through appropriate statistical analy-
ses of observational data, use of questionnaires,
biologic samples, or environmental measure-
ments (Buncher et al. 1990). For example,
exposure to lead could occur in the following
situations: A family member works in a lead
industry and carries dust home on clothing;
the interior paint contains a lead-based pig-
ment; the exterior of the neighbor’s home was
once painted with a paint containing lead, and
it has peeled off and been incorporated into the
soil where children play and may enter the
home as dust or soil carried on feet or clothing;
the family eats vegetables grown in lead-conta-
minated soil. Depending on the activity of the
child, any, all, or none of these sources of expo-
sure may be important. Exposure could be oral
only, or also by inhalation. Absorption can be
evaluated by measuring the blood lead of the
child; however, the source, route, and rate of
exposure must also be understood in order to
manage risk.
The sources of exposure to a contaminant
in the home can be evaluated from samples
of airborne, settled, or carpet/floor dust. By
knowing the time–activity patterns of the
child, estimates of the relative importance of
each source can be obtained. These observa-
tional (time–activity logs or videotapes) or
questionnaire data must be sufﬁciently detailed
to allow evaluation of the amounts of time
spent in various locations. The amount of
hand-to-mouth activity in each location or
time period is essential to understanding the
risk of exposure through the oral route, espe-
cially in young children (Buckley et al. 2001;
Dietrich et al. 1985). The potential for transfer
of a contaminant from hand to mouth can be
evaluated by collecting and analyzing hand
wipes, swipes, or rinses of objects observed to
be frequently placed in the mouth. Similarly,
detailed studies on sources of exposure to
endocrine disruptors are needed.
Data on dietary intake are essential for accu-
rate assessment of exposure to many endocrine
disruptors. Methods commonly employed
include collection and analysis of breast milk,
dietary history questionnaires, and duplicate diet
or split-plate collection and analysis of food
(National Research Council 1993).
The exposure assessment protocol must
be designed to capture information regarding
changes throughout development—from
birth through adolescence. The timing of
these data collection cycles will have to be
selected carefully to maximize the detection of
changes but not be intrusive for the partici-
pants and overly costly.
Sample Collection and Storage
for Both Short-term and Future
Work
The prenatal period is, as noted, one of great
susceptibility to adverse effects from exposures
to environmental toxicants. During these
9 months are short periods of time during spe-
cific developmental stages when the fetus is
especially susceptible to chemical or physical
insults. How do we best assess exposure to the
developing fetus during these critical periods or
subperiods? If a study is prospective, then we
can design appropriate questionnaires for the
mother and the father, recording potential
exposures and lifestyle/activity patterns.
These qualitative methods can be used to bet-
ter understand quantitative exposure measures.
To evaluate the association between fetal expo-
sure and a subsequent health outcome, it will
be necessary to collect relevant biologic speci-
mens at the proper time, store the specimens,
and conduct appropriate analyses. The timing
of sample collection is most important. The
most signiﬁcant time for the direct inﬂuence of
the father’s exposure is before conception, but
the mother’s exposure is relevant before, dur-
ing, and even after pregnancy. At least in part,
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type of specimen, and the storage conditions,
which must be used to maintain sample
integrity, are related to the toxicant or toxi-
cants of interest and its duration in the body of
a parent (Needham and Sexton 2001).
In some cases the parent compound acts
as an endocrine disruptor, whereas in other
cases metabolism of the parent compound
is required for bioactivation. For example,
alkylphenol ethoxylates used as surfactants in
many products are bioactivated in water treat-
ment plants by bacterial action that releases the
alkylphenol in free form (Jobling et al. 1996).
The insecticide DDT is metabolized in the
liver to dichlorodiphenyldichloroethylene
(DDE), which has a very long half-life and also
has the capacity to bind to androgen receptors
and act as an antiandrogen (Kelce et al. 1995).
The insecticide methoxychlor is not an
endocrine disruptor until it is demethylated in
the liver, and it is bis-hydroxymethoxychlor
that has both estrogenic and antiandrogenic
activity, not the parent compound (Gray et
al. 1999).
Toxicants can be divided into two basic
classes—those with long biologic half-lives
(persistent) and those with short half-lives
(nonpersistent)—although one should recog-
nize that there is a continuum of half-lives
between the very short and the very long lived
chemicals in the body. These half-lives may
differ from as long as decades for the persistent
toxicants to only minutes for many of the non-
persistent toxicants. So the timing of collection
of biologic samples for the analyses of persis-
tent toxicants is much less an issue than it is in
the collection of biologic samples for the mea-
surement of nonpersistent toxicants. For the
assessment of exposure to nonpersistent toxi-
cants, if we sample the mother only one time,
we must recognize that we are getting only a
“snapshot in time.” This is an important limi-
tation unless the exposure is continual. A more
effective but costly approach would be to ana-
lyze specimens collected numerous times dur-
ing pregnancy, thus getting several snapshots.
To assess the mother’s and fetus’s exposure
during pregnancy, the most common maternal
samples taken and stored are urine, hair, and
blood and its components, such as serum.
Saliva could also be used, but results from saliva
have not been extensively correlated with results
from other biologic matrices (Bernert et al.
2000). In general, persistent organic toxicants,
such as organochlorine pesticides, PCBs, and
polychlorinated dibenzo-p-dioxins, are mea-
sured in serum. Nonpersistent chemicals or
their metabolites, such as the organophosphate
pesticides, polyaromatic hydrocarbons, phytoe-
strogens, and many inorganic elements, are
generally measured in urine. Yet a number of
exceptions to these guidelines, such as the phy-
toestrogens, certain polyaromatic hydrocarbons,
and inorganic elements such as lead and cad-
mium, can be measured in blood. Also, hair is
often used to assess past exposures to inorganic
elements, such as arsenic and mercury, and has
also been used to assess exposure to selected
organic toxicants (Paschal et al. 1989).
Blood is often analyzed either as whole
blood itself, as a liquid or spotted on filter
paper, or as one of its components, such as
serum or plasma. The blood spots are the
most easily stored and have the advantage of
having the entire blood sample, including the
DNA component, which is important because
of the increasing interest in studying the inter-
action between genetics and environmental
exposure. However, the disadvantage is the
small volume of blood available from the
blood spots. Serum has the advantage of being
able to be harvested in relatively large quanti-
ties and stored in a homogeneous manner at
low temperatures, such as –70°C, at which
temperature there is little if any enzyme activ-
ity. To obtain serum, no chemicals need to be
added during blood collection to induce or
prevent clotting. Many persistent, lipophilic
environmental chemicals such as dioxins are
measured in serum and reported in terms of
the whole weight of the serum used as well as
the lipid content of the serum.
Beyond blood, the biologic ﬂuid most fre-
quently sampled and analyzed postpregnancy
is mother’s breast milk. Milk is an ideal
matrix for measuring many persistent chemi-
cals, which tend to be lipophilic. Because
milk is relatively high in lipid content, these
chemicals are found in higher concentrations
in milk than in blood. The measurement of
persistent toxicants in milk, which is taken
postpregnancy, can be used to estimate the
infant’s intake. Milk can be used as the matrix
for assessing what the mother’s internal dose
levels were during pregnancy as well as the
exposure to the fetus and then postnatally
to the newborn, whose main exposure to
these types of chemicals is through the milk
(LaKind et al. 2001).
Direct measures of assessing fetal expo-
sures are difficult and may not represent the
entire span of fetal life. Fetal matrices used in
such assessments include the amniotic fluid
(usually taken in early second trimester);
meconium; cord blood, including blood
spots; and the umbilical cord. Each of these
has advantages and disadvantages, but none
reflects the entire fetal life span. However,
meconium potentially reﬂects exposure from
the 12th to 16th week of gestation until
birth; hence, meconium is being validated as a
matrix for assessing cumulative fetal exposure
(Whyatt and Barr 2001). The most fre-
quently analyzed of these matrices is the cord
blood, usually as serum, but again, blood
spots have the advantages of containing DNA
and being easy to store.
Sample Analysis
Desirable characteristics of analytic methods
for measuring chemicals in samples of small
volume or small weight include speciﬁcity (the
ability to distinguish toxicants from each other
and from background levels), sensitivity, accu-
racy, precision, and ruggedness (Needham et
al. 2002). The laboratory worker should han-
dle each biologic specimen as potentially
containing infectious agent, and appropriate
clothing should be worn; work should be
done in a certiﬁed hood; and organic solvents
should be added to kill the agent. Other goals
for the analytic methods include their being
fast and inexpensive (Needham and Sexton
2001). Of course, few methods, if any, meet
all of these criteria. Generally, the methods
and equipment used to meet the ﬁrst series of
requirements do not meet the goals of being
fast and inexpensive. However, that does not
mean we should not attempt to meet all the
criteria. We need to state our objective clearly
and realize that there are many times when we
can use “chemical class-screening methods,”
which allow us to get the needed information.
Using dioxin and related compounds as
an example, if one is interested only in assess-
ing the total number of toxic equivalents,
bioassays and immunoassays have been devel-
oped for measuring this class of compounds.
For instance, the toxic equivalency approach
can be used to assess the presence of chemicals
that act like 2,3,7,8-tetrachlorodibenzo-p-
dioxin (Birnbaum 1999). However, this class-
screening methodology should be validated
and calibrated against the “gold standard”
method in that field, which in this example
would be high-resolution mass spectrometry
(National Academy of Sciences 1989a,
1989b). Regardless of the exact method used,
we must be able to defend the data, which
means that we must have a strict quality
control/quality assurance plan in effect.
A component of this plan is the necessary
information to merge data from ever-improv-
ing analytic techniques. Over the duration of a
longitudinal study, it is likely that the analytic
method and the limits of detection for many
toxicants will change, and these improvements
should be incorporated into the design.
Exposure Assessment in
Hypothesis Testing and in
Hypothesis Generation
In the workshop, only broad issues of expo-
sure assessment could be discussed, because
the exposure assessment strategy used in a par-
ticular study would depend on the specific
research questions to be addressed, the popula-
tion(s) to be studied, and the toxicants initially
identiﬁed to be of interest.
Here we review the important issue of the
constant collaboration that is required at
every stage of development of a study design
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status/outcome researchers in a study of
endocrine-disrupting chemicals. In designing
an exposure assessment strategy, it is recom-
mended that some exposures be selected a
priori for hypothesis testing, and that the
overall design be sufficient to allow for
hypothesis-generating analyses as more is
learned. The exposure assessment protocols
must be sufficient to address the a priori
research questions; however, the collection,
storage, and retention of questionnaire infor-
mation and biologic samples are also impor-
tant and may permit subsequent examination
of other hypotheses.
The research questions to be investigated
dictate the selection of the population to be
examined. For example, if the goal is to develop
data on the population as a whole, random
sampling from a population that has the demo-
graphics of U.S. residents may be appropriate.
However, exposures of interest may not be uni-
formly distributed throughout the population.
For example, 1–3% of women nationwide are
considered to be high consumers of ﬁsh that
may be contaminated with PCBs. A random
sample would not include sufﬁcient numbers of
these women to detect increased exposure, but
a stratiﬁed sampling of women in speciﬁc geo-
graphic regions focusing on ﬁsh eaters would
provide data from this small part of the overall
population distribution. Alternatively, these
questions can be posed as specialized studies
among higher exposed populations.
Human variation is a topic of increasing
interest in risk assessment. Just as we consider
multiple exposure pathways (diet, hand-to-
mouth activity, dermal, inhalation) and mul-
tiple exposure periods (in utero exposure due
to maternal exposure before and during
pregnancy, lactational exposure, and other
childhood exposures from birth through
adolescence), we can also think of casting a
wider net in terms of the diversity of the
study population. There has been increasing
interest in answering questions about various
populations that are not routinely included in
epidemiologic studies. Additionally, in these
populations we may see high-intensity expo-
sures due to different dietary patterns and
cultural practices. A more complete picture of
genetic polymorphisms that can alter suscep-
tibility to the effects of endocrine disruptors
may also be identified in these populations.
Oversampling these populations may be nec-
essary to obtain an adequate sample size for
statistical analysis.
Cumulative risk is another topic of increas-
ing importance in risk assessment. A cumula-
tive risk approach goes beyond identifying
effects of individual endocrine disruptors by
considering the possibly additive, antagonistic,
or synergistic activity of simultaneous expo-
sures to many agents that may affect children’s
health (Rajapakse et al. 2002). Future cumula-
tive risk assessments will consider a) how expo-
sures to multiple agents alter the toxicity of
endocrine disruptors, b) how genes, life stages,
lifestyles, and diseases can affect the toxicity of
endocrine disruptors, and c) how exposure to
endocrine disruptors can alter the toxicity of
other agents. To address these questions, it is
important to collect data on the principal
chemical and nonchemical agents that can
interact with endocrine disruptors. This will
improve our ability to understand associations
that will be identified between exposure to
endocrine disruptors and children’s health, and
ultimately will help us develop approaches to
reduce exposure.
Summary
The development of an exposure assessment
strategy for examining a range of complex
chemical exposures to the developing human
in a prospective longitudinal study from con-
ception through adolescence will be a challeng-
ing task. We have attempted to discuss many
of the relevant issues in developing an exposure
assessment protocol for such a study. Each is
summarized below.
Routes of exposure. Transplacental, lacta-
tional, diet, and hand-to-mouth exposures are
particularly important for children, and each
needs to be examined. Any strategy to charac-
terize dose from external and internal measures
of exposure of endocrine-disrupting chemicals
should be designed to capture sufﬁcient data to
evaluate all relevant routes of exposure.
Timing, frequency, and duration of expo-
sure. Animal studies show that the life stage
most susceptible to endocrine disruption is the
embryo/fetus. Such studies show that exposure
to endocrine-disrupting chemicals during fetal
development can exert qualitatively different
effects than can the same exposures after birth.
We consider it likely that as more data become
available, a similar pattern will also be seen
from exposure during other developmental
periods: neonatal life, infancy, childhood, and
adolescence. Research study designs must cap-
ture data on timing of exposure in the course
of the child’s development and the intensity,
frequency, and duration of exposures.
Qualitative and quantitative data needs.
Qualitative data from observations and ques-
tionnaires are needed to interpret measures of
exposure and, in the absence of quantitative
measurements, to provide surrogate indicators
of exposure. For example, the past history of
many potential exposures can be elicited dur-
ing an interview; among some interviewed
women, pregnancy will occur, and biologic
samples may be collected to estimate body
burden of the mother through which fetal
exposure may occur. The combination of
qualitative and quantitative data will allow
analyses to detect associations between the two
research methods. These results will become
the foundation of developing methods to
assess risk in the population at large where
only qualitative interview data are available.
Sample collection and storage. Methods for
the collection and storage of relevant biologic
specimens as well as the timing of the collec-
tion must be carefully considered in study
design. Careful documentation of the proce-
dures is required. No single protocol will be
appropriate for all toxicants or for all matrices
in which a single toxicant can be measured.
Careful archiving of biologic material will
allow evaluation of future hypotheses, at a sub-
stantially reduced cost.
Sample analysis. Analytic methods must be
fully documented and a quality control/quality
assurance plan developed and implemented.
Criteria to be considered in selection of a
method are specificity, sensitivity, accuracy,
precision, ruggedness, time of analysis, and cost.
Exposures assessed for hypothesis testing
and hypothesis generation. In any long-term
research project, there are initial, a priori ques-
tions to be investigated. The exposure assess-
ment protocol must provide sufﬁcient data for
the evaluation of these research questions.
However, the exposure assessment team may
go further and develop a protocol to collect
additional data, reasonably anticipated to be
useful over the course of the study to answer
questions not posed at the outset. For exam-
ple, the collection of a full residential history
may be useful in identifying the potential
exposure from mobile or fixed-site ambient
sources. Special attention will be needed to
ensure that enough additional data are col-
lected to enable identiﬁcation of an appropri-
ate control population for each research
question, including both a priori questions
and those that may arise in the future.
In a collaborative process of research
methodology development, we believe that
credible exposure assessment protocols can be
designed to address a priori hypotheses and to
allow for investigation of other research ques-
tions, as the state of knowledge and level of
analytic technology increases. Design of state-
of-the art exposure assessment protocols
requires resources. Adequate funds for this
aspect of a research initiative will provide data
for both hypothesis testing and hypothesis gen-
eration. Ultimately, the investment will pro-
vide the basis for public health improvements.
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